We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Find out about the long-term effects some people can have after having COVID-19.
Explains how conditions attached to a planning permission should be used and discharged effectively
You’re disabled under the Equality Act 2010 if you have a physical or mental impairment that has a 'substantial' and 'long-term' negative effect on your ability to do daily activities
Share a summary of a lasting power of attorney (LPA) with an organisation, add an LPA summary, keep track of which organisations can view an LPA summary.
Advises on how planning can manage potential noise impacts in new development.
How to make a negligible value claim for unquoted shares, and how to check if shares previously quoted on the London Stock Exchange now have negligible value.
Guidance for people with symptoms of a respiratory infection including COVID-19, or a positive test result for COVID-19.
Organisational definitions of terms concerned with risk and risk-related matters.
How to stop being an attorney under a lasting power of attorney (LPA).
Check a summary of a lasting power of attorney (LPA).
Legal rules for trustees when deciding whether to accept, refuse or return a donation.
Data on the real-world efficacy of the COVID-19 vaccines.
Healthcare professionals prescribing fluoroquinolone antibiotics (ciprofloxacin, delafloxacin, levofloxacin, moxifloxacin, ofloxacin) are reminded to be alert to the risk of disabling and potentially long-lasting or irreversible side effects. Do not prescribe fluoroquinolones for non-severe or self-limiting infections, or for mild to...
How to assess a planning application when there are protected species on or near a proposed development site.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey.